Status:
COMPLETED
Clinical Application of Patented Lyophilized PLT in Acne Scar Repairment.
Lead Sponsor:
Shin Kong Wu Ho-Su Memorial Hospital
Collaborating Sponsors:
Spirit Scientific
Conditions:
Atrophic Acne Scar
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
All kinds of skin problems will cause a person's life caused by varying degrees of trouble, especially issues at face. No matter diseases or aging would cause mental pressure and the inconvenience in ...
Eligibility Criteria
Inclusion
- \- all subjects of acne scars are defined of grades 1, 2, and 3 \[Goodman and Baron Grading scale\] were enrolled in the study.
Exclusion
- Exclusion criteria included treatment with any laser device treatment to the face within 1 month, use of systemic retinoids within 3 months, pregnancy or lactation, a history of hypertrophic scarring or keloids, cancer therapies, uncontrolled diabetes, chronic liver or kidney disease, cardiovascular disease or hematologic disorders. Subjects were requested to avoid using any topical products containing alpha-hydroxy acids and salicylic acid on the face during the study period.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04829370
Start Date
March 20 2020
End Date
October 30 2020
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan